MWNA
OCGN icon

Marshall Wace North America’s Ocugen OCGN Stock Holding History

Marshall Wace North America’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,328
Closed -$131K – 1625
2021
Q2 		$131K Buy
+16,328
New +$138K ﹤0.01% 1378

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Marshall Wace North America's OCGN Position: Q3 2021 in Review

Marshall Wace North America sold out of Ocugen (OCGN) in Q3 2021, closing a stake of 16,328 shares — an estimated $131K sold.

Marshall Wace North America first reported a position in OCGN in Q2 2021 and held it in 1 quarter. The position peaked at $131K in Q2 2021. 116 funds tracked by Wall St. Rank hold OCGN as of Q3 2021.

  • Marshall Wace North America reported no remaining Ocugen position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 16,328 Ocugen shares in Q3 2021, an estimated $131K.
  • Marshall Wace North America first reported a position in Ocugen in Q2 2021 and held it in 1 quarter.
  • Marshall Wace North America's Ocugen position peaked at $131K in Q2 2021.
  • 116 funds tracked by Wall St. Rank held Ocugen as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.